INOINOVIO PHARMACEUTICALS, INC.

Nasdaq inovio.com


$ 11.49 $ 0.22 (2 %)    

Tuesday, 14-May-2024 13:19:07 EDT
QQQ $ 443.82 $ -0.96 (-0.22 %)
DIA $ 394.00 $ -1.09 (-0.28 %)
SPY $ 521.04 $ -1.14 (-0.22 %)
TLT $ 90.72 $ 0.11 (0.12 %)
GLD $ 217.89 $ 0.05 (0.02 %)
$ 11.36
$ 11.27
$ 11.31 x 100
$ 14.44 x 100
$ 11.13 - $ 11.49
$ 3.89 - $ 14.75
342,374
na
264.59M
$ 0.88
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-06-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-12-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-14-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-15-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-14-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 03-16-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stephens--co-initiates-coverage-on-inovio-pharmaceuticals-with-overweight-rating-announces-price-target-of-20

Stephens & Co. analyst Sudan Loganathan initiates coverage on Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight rati...

 inovio-pharmaceuticals-q1-2024-gaap-eps-131-misses-100-estimate

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(1.31) per share which missed the analyst consensus estimate ...

 inovio-pharmaceuticals-form-13g-shows-deep-track-capital-lp-reported-a-999-stake-in-the-co-as-of-april-16-2024

- SEC Filing

 why-skillsoft-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...

 inovio-pharmaceuticals-stock-is-diving-today-whats-happening

Inovio announced the pricing of an underwritten offering of 2,536,258 shares of its common stock at an offering price of $7.693...

 why-macatawa-bank-shares-are-trading-higher-by-around-37-here-are-20-stocks-moving-premarket

Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corpora...

 live-nation-entertainment-groupon-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday.

 reported-earlier-inovio-prices-36m-underwritten-offering-of-2536258-common-stock-at-7693share

INOVIO Pharmaceuticals announced the pricing of an underwritten offering of 2,536,258 shares of its common stock at an offering...

Core News & Articles

https://twitter.com/DrTedros/status/1778423967105139108  

 oppenheimer-maintains-outperform-on-inovio-pharmaceuticals-maintains-40-price-target

Oppenheimer analyst Hartaj Singh maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Outperform and maintains $40 price tar...

 rbc-capital-reiterates-sector-perform-on-inovio-pharmaceuticals-maintains-11-price-target

RBC Capital analyst Gregory Renza reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Sector Perform and maintains $11 pri...

 victorias-secret-inovio-pharmaceuticals-broadcom-aptorum-group-tesla-why-these-5-stocks-are-on-investors-radars-today

Wednesday: Dow up 0.2% at 38,661.05, S&P 500 up 0.5% to 5,104.76, Nasdaq up 0.6% at 16,031.54.

 inovio-pharmaceuticals-q4-2023-gaap-eps-1100-beats-1270-estimate-sales-103000k-miss-344200k-estimate

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(1.100) per share which beat the analyst consensus estimate o...

 earnings-scheduled-for-march-6-2024

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION